SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000885590-11-000025
Filing Date
2011-05-13
Accepted
2011-05-13 13:48:17
Documents
1
Period of Report
2011-05-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6989
  Complete submission text file 0000885590-11-000025.txt   8560
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 PROSPECT STREET MADISON NJ 07940
Business Address
Durham Mark Andrew (Reporting) CIK: 0001477126 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 11839649